Nutriband extends AVERSA patent to Macao; now covered in 46 countries

NutriBand Inc.

Macao IP Office assigned patent number J/9010 with entry date December 17, 2024.
AVERSA abuse-deterrent technology now patented in 46 countries and territories.
Company targets FDA submission for AVERSA Fentanyl in first half of 2025.
AVERSA Fentanyl has potential peak US sales of $80M to $200M per Health Advances report.
Partnership with Kindeva Drug Delivery for lead product using FDA-approved fentanyl patch system.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.